Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever

被引:0
作者
Haznedaroglu, S
Öztürk, MA
Sancak, B
Goker, B
Onat, AM
Bukan, N
Ertenli, I
Kiraz, S
Calguneri, M
机构
[1] Gazi Univ, Sch Med, Dept Rheumatol, Ankara, Turkey
[2] Gazi Univ, Sch Med, Dept Biochem, Ankara, Turkey
[3] Hacettepe Univ, Sch Med, Dept Rheumatol, Ankara, Turkey
关键词
familial Mediterranean fever; interleukin; 17; 18;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Familial Mediterranean fiver (FMF) attacks are characterized by serosal inflammation rich in PMNL leukocytes and activation of a definite cytokine network. Moreover there is sustained inflammation in attack-free FMF patients. Interleukin (IL)-17 and IL-18 art recently described proinflammatory cytokines, which Can modulate certain neutrophil functions. fit this study we measured serum levels of IL-17 and IL-18 in FMF patients. Methods. The study groups comprised of 18 FMF patients in attack-free period (mean age: 30.2 +/- 9.5 years; male/female: 10/8), and 18 patients with an acute FMF attack (mean age: 25.4 4.9 years; male/female: 10/8). Twenty age-matched healthy subjects were included as a control group (male/female: 10/10). Levels of IL-17 and IL-18 were determined by commercial ELISA kits (Biosource International, USA). Results. Serum IL-17 levels were 42.8 +/- 3.7, 42.7 +/- 3.2, and 39.9 +/- 2.3 pg/mL for FMF patients in attack free period, FMF patients with acute attack, and healthy controls, respectively Serum IL-18 levels were 878.8 +/- 315.0, 854.2 +/- 261.4, and 314.6 +/- 80.8 pg/mL for FMF patients in an attack-free period, FMF patients with acute attack, and health), controls, respectively. Levels of both IL-17 and IL-18 were significantly higher in FMF patients with and without acute attack compared to control group (p < 0.05). Concentrations of those cytokines were comparable in FMF patients with acute attack and in attack-free period (p > 0.05). Conclusion. Our data suggest that IL-17 and IL-18 contribute to the cytokine network in the inflammatory cascade of FMF. However, their roles for the initiation of FMF attacks remain to be established.
引用
收藏
页码:S77 / S80
页数:4
相关论文
共 50 条
  • [1] Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever
    Direskeneli, H
    Ozdogan, H
    Korkmaz, C
    Akoglu, T
    Yazici, H
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (09) : 1983 - 1986
  • [2] Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever
    Eren Erken
    Huseyin T. E. Ozer
    Ramazan Gunesacar
    Rheumatology International, 2006, 26 : 862 - 864
  • [3] Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever
    Erken, E
    Ozer, HTE
    Gunesacar, R
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (09) : 862 - 864
  • [4] Longitudinal analysis of serum interleukin-18 in patients with familial Mediterranean fever carrying MEFV mutations in exon 10
    Wada, Taizo
    Toma, Tomoko
    Miyazawa, Hanae
    Koizumi, Eiko
    Shirahashi, Tetsujiro
    Matsuda, Yusuke
    Yachie, Akihiro
    CYTOKINE, 2018, 104 : 143 - 146
  • [5] Relationship between serum interleukin-1β levels and acute phase response proteins in patients with familial Mediterranean fever
    Yildirim, Kadir
    Uzkeser, Hulya
    Keles, Mustafa
    Karatay, Saliha
    Kiziltunc, Ahmet
    Kaya, Muhammet Dursun
    Yildirim, Abdulkadir
    BIOCHEMIA MEDICA, 2012, 22 (01) : 109 - 113
  • [6] Interleukin-21 and Interleukin-23 levels in familial Mediterranean Fever before and after treatment: the role of cytokines in disease pathogenesis
    Hizal, Mutlu
    Tufan, Abdurrahman
    Mercan, Ridvan
    Pasaoglu, Ozge Tugce
    Pasaoglu, Hatice
    Haznedaroglu, Seminur
    Goker, Berna
    Ozturk, Mehmet Akif
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Efficacy of Interleukin-1 Targeting Treatments in Patients with Familial Mediterranean Fever
    Pinar Cetin
    Ismail Sari
    Betul Sozeri
    Ozlem Cam
    Merih Birlik
    Nurullah Akkoc
    Fatos Onen
    Servet Akar
    Inflammation, 2015, 38 : 27 - 31
  • [8] Anti-Interleukin-1 Treatment In 19 Patients with Familial Mediterranean Fever
    Kucuksahin, Orhan
    Ilgen, Ufuk
    Ates, Askin
    Gumuskemer, Tolga
    Kinikli, Gulay
    Turgay, Murat
    Duzgun, Nursen
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S5 - S5
  • [9] Efficacy of Interleukin-1 Targeting Treatments in Patients with Familial Mediterranean Fever
    Cetin, Pinar
    Sari, Ismail
    Sozeri, Betul
    Cam, Ozlem
    Birlik, Merih
    Akkoc, Nurullah
    Onen, Fatos
    Akar, Servet
    INFLAMMATION, 2015, 38 (01) : 27 - 31
  • [10] Serum soluble fas ligand levels in familial Mediterranean fever
    Ceri, Mevlut
    Unverdi, Selman
    Senes, Mehmet
    Altay, Mustafa
    Yilmaz, Rahmi
    Yucel, Dogan
    Duranay, Murat
    RENAL FAILURE, 2013, 35 (06) : 835 - 837